Logo image of BYSI

BEYONDSPRING INC (BYSI) Stock Overview

NASDAQ:BYSI - KYG108301006 - Common Stock

1.72 USD
-0.08 (-4.44%)
Last: 8/29/2025, 8:09:26 PM
1.72 USD
0 (0%)
After Hours: 8/29/2025, 8:09:26 PM

BYSI Key Statistics, Chart & Performance

Key Statistics
52 Week High3.44
52 Week Low0.98
Market Cap69.35M
Shares40.32M
Float34.17M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.27
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO03-09 2017-03-09
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


BYSI short term performance overview.The bars show the price performance of BYSI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15

BYSI long term performance overview.The bars show the price performance of BYSI in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 40 60 80

The current stock price of BYSI is 1.72 USD. In the past month the price decreased by -16.91%. In the past year, price decreased by -15.69%.

BEYONDSPRING INC / BYSI Daily stock chart

BYSI Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19.87 371.68B
AMGN AMGEN INC 13.19 154.89B
GILD GILEAD SCIENCES INC 14.6 140.17B
VRTX VERTEX PHARMACEUTICALS INC 23.08 100.25B
REGN REGENERON PHARMACEUTICALS 12.72 61.55B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 58.53B
ARGX ARGENX SE - ADR 76.83 43.59B
ONC BEONE MEDICINES LTD-ADR 6.16 36.38B
INSM INSMED INC N/A 28.77B
BNTX BIONTECH SE-ADR N/A 24.04B
NTRA NATERA INC N/A 23.09B
BIIB BIOGEN INC 8.26 19.38B

About BYSI

Company Profile

BYSI logo image BeyondSpring, Inc. engages in the development and commercialization of immuno-oncology cancer therapies. The company is headquartered in Florham Park, New Jersey and currently employs 40 full-time employees. The company went IPO on 2017-03-09. The firm is focused on developing therapies to improve clinical outcomes for patients with high unmet medical needs. Its lead asset, Plinabulin, is in late-stage clinical development as an anti-cancer agent in non-small cell lung cancer (NSCLC) and a range of cancer indications. The Company’s mechanism of action as a dendritic cell maturation agent supports both anti-cancer activity and immune modulation, offering an approach to resensitizing tumors to checkpoint inhibitors. The company also has a pipeline of immuno-oncology product candidates, BPI-002 program, which is based on an oral small molecule agent that increases T-cell co-stimulation; BPI-003 program, which is based on a small molecule inhibitor of IKK, a protein kinase, and BPI-004 program, which is focused on a small molecule that induces the production of neo-antigens by tumor cells, allowing tumors containing no immune cells to be infiltrated by the immune system.

Company Info

BEYONDSPRING INC

100 Campus Drive, West Side, 4Th Floor, Suite 410

Florham Park NEW JERSEY 10005 US

CEO: Lan Huang

Employees: 40

BYSI Company Website

BYSI Investor Relations

Phone: 16465284184

BEYONDSPRING INC / BYSI FAQ

What is the stock price of BEYONDSPRING INC today?

The current stock price of BYSI is 1.72 USD. The price decreased by -4.44% in the last trading session.


What is the ticker symbol for BEYONDSPRING INC stock?

The exchange symbol of BEYONDSPRING INC is BYSI and it is listed on the Nasdaq exchange.


On which exchange is BYSI stock listed?

BYSI stock is listed on the Nasdaq exchange.


What is BEYONDSPRING INC worth?

BEYONDSPRING INC (BYSI) has a market capitalization of 69.35M USD. This makes BYSI a Micro Cap stock.


How many employees does BEYONDSPRING INC have?

BEYONDSPRING INC (BYSI) currently has 40 employees.


What are the support and resistance levels for BEYONDSPRING INC (BYSI) stock?

BEYONDSPRING INC (BYSI) has a support level at 1.71 and a resistance level at 1.73. Check the full technical report for a detailed analysis of BYSI support and resistance levels.


Should I buy BEYONDSPRING INC (BYSI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BEYONDSPRING INC (BYSI) stock pay dividends?

BYSI does not pay a dividend.


What is the Price/Earnings (PE) ratio of BEYONDSPRING INC (BYSI)?

BEYONDSPRING INC (BYSI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.27).


What is the Short Interest ratio of BEYONDSPRING INC (BYSI) stock?

The outstanding short interest for BEYONDSPRING INC (BYSI) is 6.33% of its float. Check the ownership tab for more information on the BYSI short interest.


BYSI Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

BYSI Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to BYSI. BYSI has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BYSI Financial Highlights

Over the last trailing twelve months BYSI reported a non-GAAP Earnings per Share(EPS) of -0.27. The EPS increased by 49.06% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -35.83%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%75.9%
Sales Q2Q%-100%
EPS 1Y (TTM)49.06%
Revenue 1Y (TTM)N/A

BYSI Forecast & Estimates


Analysts
Analysts85.71
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

BYSI Ownership

Ownership
Inst Owners14.41%
Ins Owners15.26%
Short Float %6.33%
Short Ratio27.84